FRI0381 Interferon Dysregulation in an Academic SLE Cohort is Associated with Distinct Signaling Differences in Blood Neutrophils VS. Peripheral Blood Mononuclear Cells
Wendy I. White(University of North Carolina at Chapel Hill), M. Pétri(Johns Hopkins University), Reynald Lescarbeau(Tufts University), David A. Drubin(Selventa (United States)), Rongdong Zeng, Michael Macoritto(Selventa (United States)), Aaron Van Hooser(Selventa (United States)), Yanyao Wu, Lu Yang(Weifang Medical University), Morven Roberts, Xiang Guo
Cited by 0
Related Papers
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Silencing of <i>Sl<scp>PL</scp></i>, which encodes a pectate lyase in tomato, confers enhanced fruit firmness, prolonged shelf‐life and reduced susceptibility to grey mould
|Plant Biotechnology Journal|2017|275
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168
Overexpression of a tomato miR171 target gene <i>Sl<scp>GRAS</scp>24</i> impacts multiple agronomical traits via regulating gibberellin and auxin homeostasis
|Plant Biotechnology Journal|2016|165
Significance of LL‐37 on Immunomodulation and Disease Outcome
|BioMed Research International|2020|133